PriceTargets.com logo

CannTrust - CTST Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.64 As of 04/14/2020 01:00 AM ET
+0 (0.00%)
Get New CannTrust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTST and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTST

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for CannTrust in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$0.64.

This chart shows the closing price for CTST for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in CannTrust. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/10/2019Bloom BurtonDowngradeBuy ➝ HoldHigh
7/9/2019Roth CapitalReiterated RatingBuy ➝ NeutralLow
7/8/2019Eight CapitalDowngradeBuy ➝ NeutralHigh
7/8/2019Bank of AmericaDowngradeBuy ➝ Underperform$9.00 ➝ $4.50High
7/3/2019CitigroupInitiated CoverageBuy$7.00 ➝ $7.00Low
6/20/2019Bank of AmericaSet TargetBuy$7.00Medium
5/30/2019BMO Capital MarketsUpgradeMarket Perform ➝ OutperformHigh
5/24/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$11.00 ➝ $5.69High
5/23/2019Paradigm CapitalReiterated RatingBuyMedium
5/15/2019Bloom BurtonUpgradeAccumulate ➝ BuyMedium
(Data available from 4/25/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
CannTrust logo
CannTrust Holdings Inc. produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.
Read More

Today's Range

Now: C$0.64
Low: C$0.64
High: C$0.64

50 Day Range

MA: C$0.64
Low: C$0.64
High: C$0.64

52 Week Range

Now: C$0.64
Low: C$0.38
High: C$8.17

Volume

N/A

Average Volume

N/A

Market Capitalization

C$90.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of CannTrust?

The following sell-side analysts have issued reports on CannTrust in the last twelve months:
View the latest analyst ratings for CTST.

What is the current price target for CannTrust?

0 Wall Street analysts have set twelve-month price targets for CannTrust in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for CannTrust in the next year.
View the latest price targets for CTST.

What is the current consensus analyst rating for CannTrust?

CannTrust currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CTST.

What other companies compete with CannTrust?

Other companies that are similar to CannTrust include Milestone Pharmaceuticals, BioXcel Therapeutics, BeyondSpring, SELLAS Life Sciences Group and DiaMedica Therapeutics. Learn More about companies similar to CannTrust.

How do I contact CannTrust's investor relations team?

CannTrust's physical mailing address is 3280 LANGSTAFF ROAD UNIT 1, VAUGHAN A6, L4K 4Z8. The company's listed phone number is 64-7872-2300 and its investor relations email address is [email protected]. The official website for CannTrust is www.canntrust.ca. Learn More about contacing CannTrust investor relations.